NO20052422D0 - Stabiliserte, fast tilstand polypeptidpartikler. - Google Patents

Stabiliserte, fast tilstand polypeptidpartikler.

Info

Publication number
NO20052422D0
NO20052422D0 NO20052422A NO20052422A NO20052422D0 NO 20052422 D0 NO20052422 D0 NO 20052422D0 NO 20052422 A NO20052422 A NO 20052422A NO 20052422 A NO20052422 A NO 20052422A NO 20052422 D0 NO20052422 D0 NO 20052422D0
Authority
NO
Norway
Prior art keywords
solid state
stabilized solid
polypeptide particles
state polypeptide
particles
Prior art date
Application number
NO20052422A
Other languages
English (en)
Other versions
NO20052422L (no
Inventor
Johanna Bentz
Ling-Ling Kang
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Publication of NO20052422D0 publication Critical patent/NO20052422D0/no
Publication of NO20052422L publication Critical patent/NO20052422L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/2278—Vasoactive intestinal peptide [VIP]; Related peptides (e.g. Exendin)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/02—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/19—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles lyophilised, i.e. freeze-dried, solutions or dispersions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/183—Amino acids, e.g. glycine, EDTA or aspartame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Vascular Medicine (AREA)
  • Inorganic Chemistry (AREA)
  • Dermatology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20052422A 2002-10-29 2005-05-19 Stabiliserte, fast tilstand polypeptidpartikler. NO20052422L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US42228902P 2002-10-29 2002-10-29
PCT/US2003/034229 WO2004039392A2 (en) 2002-10-29 2003-10-28 Stabilized, solid-state polypeptide particles

Publications (2)

Publication Number Publication Date
NO20052422D0 true NO20052422D0 (no) 2005-05-19
NO20052422L NO20052422L (no) 2005-07-20

Family

ID=32230336

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20052422A NO20052422L (no) 2002-10-29 2005-05-19 Stabiliserte, fast tilstand polypeptidpartikler.

Country Status (20)

Country Link
US (1) US20060198894A1 (no)
EP (1) EP1562626B1 (no)
JP (1) JP2006504772A (no)
KR (1) KR20050083841A (no)
CN (1) CN1708314A (no)
AU (1) AU2003285075B2 (no)
BR (1) BR0315782A (no)
CA (1) CA2502378A1 (no)
DE (1) DE60317822D1 (no)
EC (1) ECSP055822A (no)
IL (1) IL168106A0 (no)
MX (1) MXPA05004593A (no)
MY (1) MY138608A (no)
NO (1) NO20052422L (no)
NZ (2) NZ562480A (no)
PL (1) PL376219A1 (no)
RU (1) RU2329823C2 (no)
TW (1) TW200505497A (no)
WO (1) WO2004039392A2 (no)
ZA (1) ZA200504311B (no)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2005012347A2 (en) 2003-08-05 2005-02-10 Novo Nordisk A/S Novel insulin derivatives
US20190330295A1 (en) * 2005-05-04 2019-10-31 Zealand Pharma A/S Glucagon-like-peptide-2 (glp-2) analogues
EP1969004B1 (en) 2005-12-28 2011-08-10 Novo Nordisk A/S Compositions comprising an acylated insulin and zinc and method of making the said compositions
JP4847775B2 (ja) * 2006-03-29 2011-12-28 シーシーアイ株式会社 安定なポリオール脱水素酵素組成物
CN101677947B (zh) 2007-06-13 2013-07-17 诺沃-诺迪斯克有限公司 包含胰岛素衍生物的药物制剂
BRPI0919946A2 (pt) 2008-10-30 2016-02-16 Novo Nordisk As tratamento de diabetes melito usando injeções de insulina com frequência de injeção menor que diariamente
SI2603232T1 (sl) 2010-08-11 2020-03-31 Ironwood Pharmaceuticals, Inc. Stabilne formulacije linaklotida
DK2632478T3 (da) 2010-10-27 2019-10-07 Novo Nordisk As Behandling af diabetes melitus under anvendelse af insulinindsprøjtninger indgivet med varierende indsprøjtningsintervaller
WO2014177623A1 (en) 2013-04-30 2014-11-06 Novo Nordisk A/S Novel administration regime
US10335464B1 (en) 2018-06-26 2019-07-02 Novo Nordisk A/S Device for titrating basal insulin

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4816440A (en) * 1985-09-26 1989-03-28 Cetus Corporation Stable formulation of biologically active proteins for parenteral injection
US4806343A (en) * 1986-03-13 1989-02-21 University Of Southwestern Louisiana Cryogenic protectant for proteins
JPH02218618A (ja) * 1989-02-21 1990-08-31 Green Cross Corp:The トロンビン粉末製剤
US5128242A (en) * 1989-06-19 1992-07-07 The Administrators Of The Tulane Educational Fund Hypothalamic polypeptides with adenylate cyclase stimulating activity
EP0499990B1 (en) * 1991-02-19 1996-05-15 Takeda Chemical Industries, Ltd. Method for producing cysteine-free peptides
JP3356816B2 (ja) * 1992-03-24 2002-12-16 セイコーインスツルメンツ株式会社 半導体光電気変換装置
JPH083056A (ja) * 1994-06-17 1996-01-09 Nippon Kayaku Co Ltd 末梢神経障害の軽減剤
JPH08131171A (ja) * 1994-11-11 1996-05-28 Asahi Chem Ind Co Ltd 逆転写酵素の安定化組成物
US6267958B1 (en) * 1995-07-27 2001-07-31 Genentech, Inc. Protein formulation
SK285803B6 (sk) * 1996-02-02 2007-08-02 Alza Corporation Implantabilné zariadenie na dodávanie aktívneho činidla
US6395292B2 (en) * 1996-02-02 2002-05-28 Alza Corporation Sustained delivery of an active agent using an implantable system
US6156331A (en) * 1996-02-02 2000-12-05 Alza Corporation Sustained delivery of an active agent using an implantable system
US5763401A (en) * 1996-07-12 1998-06-09 Bayer Corporation Stabilized albumin-free recombinant factor VIII preparation having a low sugar content
CN1146402C (zh) * 1996-12-20 2004-04-21 阿尔萨公司 凝胶组合物及方法
AR015598A1 (es) * 1997-04-28 2001-05-16 Lilly Co Eli FORMULACIoN LIOFILIZADA QUE COMPRENDE PROTEíNA C ACTIVADA, SU USO PARA LA PREPARACIoN DE UN MEDICAMENTO Y FORMA DE DOSIS UNITARIA QUE LA COMPRENDE.
JP4156688B2 (ja) * 1997-07-22 2008-09-24 アルフレッサファーマ株式会社 安定なヘモグロビン含有組成物
ES2182379T3 (es) * 1997-12-22 2003-03-01 Alza Corp Membrana de regulacion del regimen de liberacion para dispositivos de administracion controlada de farmacos.
PT1041974E (pt) * 1997-12-30 2007-01-31 Alza Corp Sistema de entrega de agente benéfico como obturador de membrana
ATE359809T1 (de) * 1999-05-31 2007-05-15 Mitsubishi Chem Corp Gefriergetrocknete hgf-präparationen
CA2472956A1 (en) * 2002-02-14 2003-08-21 Bayer Pharmaceuticals Corporation Formulation strategies in stabilizing peptides in organic solvents and in dried states
GB0207092D0 (en) * 2002-03-26 2002-05-08 Sod Conseils Rech Applic Stable pharmaceutical composition containing factor VIII

Also Published As

Publication number Publication date
NO20052422L (no) 2005-07-20
ECSP055822A (es) 2005-08-11
MXPA05004593A (es) 2005-07-26
ZA200504311B (en) 2006-07-26
CA2502378A1 (en) 2004-05-13
MY138608A (en) 2009-07-31
RU2329823C2 (ru) 2008-07-27
AU2003285075A1 (en) 2004-05-25
WO2004039392A2 (en) 2004-05-13
IL168106A0 (en) 2009-02-11
DE60317822D1 (de) 2008-01-10
WO2004039392A3 (en) 2004-09-30
EP1562626A2 (en) 2005-08-17
PL376219A1 (en) 2005-12-27
TW200505497A (en) 2005-02-16
JP2006504772A (ja) 2006-02-09
NZ539811A (en) 2008-08-29
RU2005116250A (ru) 2006-01-20
US20060198894A1 (en) 2006-09-07
KR20050083841A (ko) 2005-08-26
BR0315782A (pt) 2005-09-20
NZ562480A (en) 2009-08-28
CN1708314A (zh) 2005-12-14
AU2003285075B2 (en) 2009-10-29
EP1562626B1 (en) 2007-11-28

Similar Documents

Publication Publication Date Title
NO20052422D0 (no) Stabiliserte, fast tilstand polypeptidpartikler.
ATE323723T1 (de) Hasylierte polypeptide, besonders hasyliertes erythropoietin
NO20053248D0 (no) Kerosenblanding.
NO20052248D0 (no) Svivelstykkesystem.
NO20051500D0 (no) Substituerte heterocyklylpyrimidiner.
NO20051497D0 (no) Beta-laktamaseinhibitorprodrug.
FI20020881A0 (fi) Iskulaite
ITMI20032170A1 (it) Tagliacimosse.
ES1052590Y (es) Quiosco-consigna.
Lee The Future Path for the JKMA
ITMI20020288A1 (it) Do.re.mi
ITRA20020023A1 (it) Il mollino.
ES1053097Y (es) Envase-expositor mejorado.
ITRM20020216A1 (it) Interruttore di manovra-sezionatore.
ES1051605Y (es) Cromo-puzzle.
ES1052945Y (es) Contraventana.
ES1052011Y (es) Espetero.
ES1051703Y (es) Potera.
ES1052029Y (es) Balin-proyectil.
ES1051110Y (es) Caja-palet.
ES1052654Y (es) Cubitera.
ES1052938Y (es) Cantonera.
NL1020250A1 (nl) Stelwig.
ITVI20020277A1 (it) Salvapenne.
ITRE20020089A1 (it) Apparecchiatutto.

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application